“Region” Group increased its share in Pharmacy chain “36.6” – were they in control before?

36.6 Pharmacy
36.6 Pharmacy

According to open data LLC “Region Portfolio Investments” increased its share in PJSC “Pharmacy chain 36.6” from 2.67% to 14%.

“Pharmacy chain 36,6” – one of Russia’s largest pharmacy retailers, operates pharmacies under the same brand and other  pharmacy chains: “Gorzdrav”, A.v.e., etc.

In the summer of 2018 “36,6” has elected a new Board of Directors where Alexey Abolaev serves and is the General Director of open company “Region Portfolio Investments” (as per website of “Region” Group of Companies). Until 2011 this company was called MC “Portfolio Investments” and was part of “Rosneft” structure.

The fact that “Region” fully controls the operating activities of” 36.6 ” and is the largest shareholder of the retailer, confirm two sources. As of 30 June 2018 “36,6” there was no ultimate controlling owner. Cyprus “Panerio Holdings” owns 28% of the chain, another 15% of shares managed by the American pharmacy giant Walgreens Boots Alliance.

According to RNC Pharma, at the end of 2017, “36.6” managed 1.75 thousand pharmacies, occupying 5% of the market. Sales of the group for that period increased by 5% to 48.25 billion rubles, gross profit-by 14.5% to 12.32 billion rubles.

Besides, PJSC “Pharmacy Chain 36.6” is preparing to increase the authorized capital by 3.5 times, as follows from the company’s open information. The Board of Directors of the pharmacy has approved the issue of 6 billion shares with par value of RUB 0.64. Current market value of this package — 30,6 billion rubles. The Shares are to be placed by open subscription. Now the authorized capital of PJSC is divided into 2,331 billion shares. Shareholders of 36.6 will consider the issue of additional emmission at the extraordinary meeting on October 1.

Another shareholder of the chain is concern Rossium, asset Management company of Roman Avdeev – the main shareholder of Moscow Credit Bank

Be the first to comment

Leave a Reply

Your email address will not be published.